How Does Diabetes Affect Wound Care?
Diabetic foot ulcers are a serious problem related to diabetes. Diabetic foot ulcers (DFUs) are known to affect 15 percent of patients with diabetes. They are also known to be complex and challenging. This is due to chronic inflammation, biofilm, and extracellular matrix degradation. For those that develop a DFU, approximately 6% will be hospitalized due to infection or other related infections.
These types of ulcers occur mostly on the feet. Diabetes, a chronic disease in which the body is unable to use glucose properly, can cause circulation and nerve damage and can cause wounds to heal slowly. This leads to serious complications. Nerve damage or neuropathy will cause diabetics to have trouble feeling the pain of a blister or cut until the condition has significantly worsened or become infected. Diabetes can weaken an individual’s immune system, develop narrow and clogged arteries, causing wound development, making wounds prone to infection.
Wound care is the practice of taking proper care of a wound. This can range from minor and major wounds. While everyone can benefit from proper wound care, it is much more important for diabetics. Diabetics often suffer from poor blood circulation which causes wounds to heal much slower than they would in a non-diabetic.
Helpful Tips in Prevention
Collagen Dressings Used in Diabetic Foot Ulcers
It is important to properly care for diabetic wounds. Diabetics can experience dryness, itchiness, cuts, and sores on their feet. Minor issues like these can pose a serious threat to diabetic feet. Diabetic foot ulcers (DFUs) are the result of wounds healing slowly or poorly, becoming infected, or forming while healing. Podiatrists can provide the correct treatment for you if you have a wound on your feet or other skin problems. The best way to care for foot wounds is to prevent them.
Collagen advanced wound care dressings can be an effective tool of healing in diabetic foot wounds. Clinical data show an increase in faster healing rates in this population. With diabetic foot ulcers being a major contributor to recurring infections, amputation, and death, it is most important to utilize advanced wound care dressings such as collagen to optimize healing.
Diabetic wounds stall in healing due to a prolonged inflammatory response. Components of collagen such as fibroblasts and keratinocytes are all fundamentals in tissue regeneration. Collagen wound dressings such as Medifil® II Collagen Particles, Skin Temp® II Collagen Sheets, and Collatek® Collagen Gel, all contain a higher nativity that supports regulation of extracellular matrix (ECM) that supports and promotes healing.
Human BioSciences products contain a higher nativity, thereby allowing for better stability of the triple helix collagen molecule and scaffolding moving wounds towards a healing trajectory. The biotechnology collagen format is designed to provide tissue scaffolds for the cells to inhabit where the collagen matrix is ultimately reorganized to mimic the body’s own collagen that contains the major building block of connective tissues.
Benefits and Features of Kollagen Technology Products
Human BioSciences, Inc. USA takes pride in being a 32-year trusted USA manufacturer (private label and brand name), leading distributor, and multinational biotechnology company in the collagen advanced wound care industry.
Human BioSciences, Inc. blog offers education and tips; however,the information provided by this website or company is not a substitute for medical treatment or advice.
Mrs. Vann is responsible for branding, design, and public outreach efforts for the company. Mrs. Vann has over five years of experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international. She also has experience producing several television and live-stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.
Mr. Patel is the Vice President of Operations for Human BioSciences. As such, he is responsible for strategy development for optimal growth, organizing multiple teams and implementing optimal product delivery for the growth of HBS. He has served multiple positions within HBS since 2001, including Operations Manager. With an MBA in Pharmaceutical Healthcare and a Bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge in collagen product production with a rich history in managing teams.
As the President of Human BioSciences, Dr. Rohan K Jain is responsible for the company’s overall operations, with a focus on research and development. Dr. Jain has supervised and conducted extensive research in the collagen, biomaterials, and protein space, resulting in the release of numerous new products to the market. Prior to his role at HBS, Dr. Jain was a capital markets attorney at Shearman & Sterling LLP. He received his Doctorate in Law and his MBA from New York University; his Bachelor’s degrees in Biomedical Engineering and Materials Science and his Master’s in Engineering Management from Johns Hopkins University. He is a member of the New York and Maryland bars.
Cheryl Carver, LPN, WCC, CWCA, CWCP, DAPWCA, FACCWS is responsible for clinical education and training initiatives for customer accounts. Ms. Carver has amassed a wealth of clinical knowledge and industry experience in her more than 20 years as a board-certified wound care nurse. She has authored over 200 published white papers, ebooks, blogs, and articles for WoundSource and freelance.
Dr. Goebel is responsible for the company’s physical infrastructure and global expansion efforts through partnerships. Prior to joining HBS, Dr. Goebel was Managing Director at the Graf Matuschka Group in Munich, Germany, where he was actively involved in restructuring and privatization in East Germany and Eastern Europe. He was also a member of the American group of the EBRD European Bank for Reconstruction and Development in the privatization of the Russian economy and military complex. He has over forty years’ experience in many different industries including medical devices, pharmacy, and others. Dr. Goebel earned his Doctorate and Postdoctoral degrees in Economics in East Berlin.
Mr. Kumar is responsible for the company’s overall accounting and finance activities with a focus on internal control and taxation.
Mr. Kumar has over 25 years of public and corporate accounting experience. He is a Certified Public Accountant, licensed in the State of Virginia, Maryland, and Washington D.C., and an Enrolled Agent authorized to practice before the Internal Revenue Service. Mr. Kumar is also a Chartered Accountant and fellow member of the Institute of Chartered Accountants of India. Mr. Kumar received his Master’s degree in Commerce from Himalayan University in India.
Mr. Slovick is responsible for all regulatory and quality affairs in the company. Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years. He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.
Mr. Agarwal is responsible for Corporate Business Development, Sales, and Product Development, both locally and internationally for the company. Mr. Agarwal has over six years of corporate sales and business development experience. He completed his Master of Science in Engineering Management degree from Johns Hopkins University with a technical concentration in Mechanical Engineering. In the past, he has also worked as a fundraising volunteer for three years and thus gained insights in community fundraising and business development. Additionally, he has interned at a manufacturing firm and understood various intricacies involved in manufacturing ranging from the floor level to the supply chain. He has published a paper on Omni Channel Supply Chain and is a certified Lean Six Sigma associate. He has also interned as a business development consultant to a startup for market research and pricing strategies in Israel. Equipped with a combination of management and technical background acquired from his diverse experiences and education, he is perfectly suited to lead the business development efforts for Human BioSciences.
